HomeNewsPodcastSetting Sail | Here's why Ronnie Screwvala thinks a unicorn is an artificial thing

Setting Sail | Here's why Ronnie Screwvala thinks a unicorn is an artificial thing

In the latest episode of the Setting Sail podcast hosted by Moneycontrol's Priyanka Sahay, Screwvala talks about the growth expected in the ed-tech segment, his vision for upGrad, his startup and how the second wave of the pandemic is impacting the corporates in India.

May 13, 2021 / 12:05 IST
Story continues below Advertisement

Ronnie Screwvala is an investor, entrepreneur, philanthropist with a ring side view of the startup ecosystem. At a time when the ed-tech sector is booming with investments and big ticket mergers, he thinks that the real success of a startup is defined by the innovation it brings to the market. Rest everything -- unicorn status, valuation, amount of funding raised, are flawed elements.

In the latest episode of the Setting Sail podcast hosted by Moneycontrol's Priyanka Sahay, Screwvala talks about the growth expected in the ed-tech segment, his vision for upGrad, his startup and how the second wave of the pandemic is impacting the corporates in India.

Story continues below Advertisement

Tune in to know more.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show
Priyanka Sahay
first published: May 13, 2021 11:00 am

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!